Canada: Guidance issued for manufacturers of HIV RDTs for use at the point of care or for self-testing
Manufacturers of Class IV human immunodeficiency virus (HIV) rapid diagnostic tests (RDTs) intended to be used at the point of care and/or for self-testing have been provided with guidance1 on the analytical and clinical data, and the device labelling, required…

